Foghorn Therapeutics releases November 2025 investor presentation highlighting precision therapeutics

Foghorn Therapeutics Inc.

Presentation dated November 2025 focuses on the company's unique biology and precision therapeutics platform.
No specific financial results or operational updates disclosed in the filing.
The presentation is intended for use in meetings with investors.

item 7.01 item 9.01

Foghorn Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-050683

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.